Divis Laboratories Ltd | DIVI - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aurobindo Pharma INR 982.1M 54.4M 2026-03
Avita Medical AUD 1.25M 100K 2025-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Lupin INR 1.15B 73.9M 2025-12
Moderna USD 11.49B 36B 2026-03
Organon & Co USD 128M 3M 2025-09
Revvity USD 24.72M 1.2M 2026-03
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Viatris USD 120.1M 500K 2026-03
Xeris Pharmaceuticals USD 7.15M 115K 2025-12